9th Annual Summit for Women Leaders in Life Sciences Law - WEB by C5Group

EARN CLE/DIVERSITY CREDITS

Women Leaders 9TH ANNUAL SUMMIT FOR

LIFE SCIENCES LAW

July 27–28, 2022 | Omni Parker House | Boston, MA Increasing the Prominence of Women through Professional Development, Substantive Legal Discussion, and Woman-to-Woman Networking Benefit from the Insights of Our Distinguished Conference Co-Chairs: Tamara Joseph Chief Legal Officer Spero Therapeutics

KEYNOTE INTERVIEW:

SPOTLIGHT SPEAKER:

Lessons in Leadership from the Covid-19 Pandemic

Diversity, Equity and Inclusion: How to Drive Sustaining Change

Sally Susman Executive Vice President and Chief Corporate Affairs Officer Pfizer

Celeste Warren Vice President, Global Diversity & Inclusion Center of Excellence Merck

Robin Walker Chief Legal Officer Goldfinch Bio

Meet and Network with Industry-Leading Women From: ĉ ĉ ĉ ĉ ĉ

Abbott Alnylam Pharmaceuticals Bayer Biogen Bristol Myers Squibb

Supporting Sponsors

ĉ ĉ ĉ ĉ ĉ

Eisai Eli Lilly and Company EMD Serono Genentech GlaxoSmithKline

Welcome Reception Sponsor

ĉ ĉ ĉ ĉ ĉ

Goldfinch Bio Merck Moderna Olympus Corporation Pfizer Associate Sponsors

ĉ Regeneron Pharmaceuticals, Inc. ĉ Spero Therapeutics ĉ Sumitovant Biopharma

Sponsored By

Cocktail Reception Sponsor

AmericanConference.com/LSwomen • 888 224 2480

Part of C5 Group’s LIFE SCIENCES GLOBAL SERIES

After two years and much anticipation, ACI’s Flagship Summit for Women Leaders in Life Sciences Law will be returning LIVE and IN-PERSON to Boston.

his summer’s reunion event will provide the renewed opportunities for in-person networking and collaboration that you’ve been waiting for, with the chance to meet, engage with and learn from nearly 200 female attorneys and executives from the biotech, pharmaceutical, and medical device industries.

Join an exceptional group of female leaders for valuable discussions about how the latest legal, administrative, and policy developments are impacting the life sciences industry and the roles of women in it. Attend and develop strategies for rising up the leadership ranks at your organization, charting your path for continued success, overcoming the challenges of a hybrid workplace, and building and capitalizing on your personal brand to expand your industry presence. With the life sciences industry currently experiencing unprecedented growth, innovation, and visibility, it is more important than ever that women in leadership work together to increase their prominence and recognition within the field. The ACI “WILS” conference has earned its standing as the one and only forum where female leaders in the life sciences legal industry can convene, connect, and call on one another to act regarding their careers, aspirations and personal growth. We hope you will join this outstanding community of today’s as well as tomorrow’s female life sciences leaders for what will be one of the most valuable gatherings of the year.

ADVISORY BOARD FOR 2022 Lori Cohen Co-Chair, Global Litigation Chair, Pharmaceutical, Medical Device & Health Care Litigation Group Chair, Trial Practice Group Greenberg Traurig LLP (Atlanta, GA) Tamara Joseph Chief Legal Officer Spero Therapeutics (Cambridge, MA) Elona Kogan General Counsel and Corporate Secretary Seer (Redwood City, CA)

2 | #WomeninLifeSciences

Deborah Logan Associate General Counsel EMD Serono, Inc. (Rockland, MA) Donna M. Meuth Associate General Counsel, Intellectual Property Eisai Inc. (Cambridge, MA)

Elena Rossano Senior Counsel, Global Commercial Operations Amgen (New York, NY) Gael Tisack Deputy General Counsel, IP Olympus Corporation (Southborough, MA)

Honorable Teresa Rea Partner Crowell & Moring LLP (Washington, DC)

(Former Acting Under Secretary of Commerce for Intellectual Property and Former Acting Director of the United States Patent and Trademark Office)

twitter: @ACI_Pharma linkedin: ACI’s Women Leaders in Life Sciences Law

Distinguished Faculty CO-CHAIRS

Lorie Foster Division Counsel Abbott (Columbus, OH)

Tamara Joseph Chief Legal Officer Spero Therapeutics (Cambridge, MA)

Ronni Fuchs Partner Troutman Pepper (Princeton, NJ)

Robin Walker Chief Legal Officer Goldfinch Bio (Cambridge, MA)

Betania Glorio Global Chief Compliance Officer EMD Serono

SPEAKERS Amy Altshul Senior Vice President Head of Legal for Global R&D, Global Oncology and Global Commercial Activities GlaxoSmithKline (King of Prussia, PA) Sonia Chen Arnold Sr. Director, Assistant General Counsel – Consumer/Customer Operations Eli Lilly and Company (Indianapolis, IN) Rebecca Clegg Attorney Axinn, Veltrop & Harkrider LLP (Hartford, CT) Kellie Combs Partner Ropes & Gray LLP (Washington, DC) Sheila Connor Vice President and Chief US Counsel Biogen (Boston, MA) Heather J. DiPietrantonio, PhD Shareholder Wolf, Greenfield & Sacks, P.C. (Boston, MA) Joy Dowdle Partner Paul Hastings LLP (Houston, TX) Larissa Eustice Senior Assistant General Counsel Bayer (Whippany, NJ) Aileen M. Fair Senior Corporate Counsel Litigation & Government Investigations | Antitrust & Competition Law Bristol Myers Squibb (Princeton, NJ) Dorothy Flower Partner Head of Medical & Life Sciences Reynolds Porter Chamberlain (RPC) (London, UK)

Anat Hakim Senior Vice President, General Counsel and Secretary Eli Lilly and Company Alison Hanstead Partner White & Case LLP (New York, NY) Brenda Herschbach Jarrell Partner Chair, Life Sciences Group Choate Hall & Stewart LLP (Boston, MA) Diane Hilligoss Associate Vice President and Assistant General Counsel Eli Lilly and Company Lisa Jakob Managing Counsel, Trademark Group Merck (Rahway, NJ) Christiana Jacxsens Vice President Deputy General Counsel, Head of Investigations and Litigation B. Braun Medical Inc. Colleen Tracy James Partner White & Case LLP Shannon Thyme Klinger Chief Legal Officer Moderna (Cambridge, MA) Lisa LeCointe-Cephas SVP, Chief Ethics and Compliance Officer Merck (New York, NY) Diane Lifton Senior Vice President, Legal Sumitovant Biopharma, Inc. (New York, NY) Dan Liu Attorney Loeb & Loeb LLP Deborah A. Logan Associate General Counsel EMD Serono, Inc. (Rockland, MA)

Chelsea A. Loughran Shareholder Wolf, Greenfield & Sacks, P.C. (Boston, MA) Katrina Long Director, Corporate Counsel Regeneron Pharmaceuticals, Inc. (New York, NY) Jeny Maier Partner Axinn, Veltrop & Harkrider LLP (Washington, DC) Donna Meuth Associate General Counsel, Intellectual Property Eisai (Cambridge, MA) Kate Middleton Partner Co-Lead of Digital Health Artificial Intelligence Team Faegre Drinker Biddle & Reath LLP (Minneapolis, MN) Marilyn A. Moberg Partner Reed Smith LLP (Los Angeles, CA) Regina Nelson Counsel Reed Smith LLP (Philadelphia, PA) Sapna Palla Partner Allen & Overy (New York, NY) Deirdre Parsons Senior Director, Global Public Policy & Government Relations Alnylam Pharmaceuticals (Boston, MA) Lisa Pirozzolo Partner, Co-Chair, IP Litigation Practice Group Wilmer Cutler Pickering Hale and Dorr LLP (Boston, MA) Honorable Teresa Rea Partner Crowell & Moring LLP (Former Acting Director of the United States Patent and Trademark Office) Terra Reynolds Partner Latham & Watkins LLP (Chicago, IL) Carolina del Río Partner Dentons (Santiago, Chile) LaShell Robinson Director, Diversity & Inclusion in Clinical Trials Takeda Pharmaceuticals

AmericanConference.com/LSwomen • 888 224 2480

Lauren Robinson VP, Head of Legal Recruitment - Life Sciences Larson Maddox Elena Rossano Senior Counsel, Global Commercial Operations Amgen (New York, NY) Irena Royzman Partner, Head of Life Sciences Kramer Levin Naftalis & Frankel LLP Melanie Rupert Partner Paul Hastings LLP (New York, NY) Prajakta Sonalker Counsel Venable LLP (New York, NY) Sally Susman Executive Vice President and Chief Corporate Affairs Officer Pfizer (New York, NY) Sheea Sybblis Assistant General Counsel & Practice Group Leader Genentech (New York, NY) Yoshie Tanigawara Associate Director, Corporate Strategy Eisai Co., Ltd. Sara Thompson Shareholder Chair, Pharmaceutical, Medical Device & Health Care Litigation Practice Greenberg Traurig LLP (Atlanta, GA) Gael Tisack Global Head of Intellectual Property Olympus Corporation (Southborough, MA) Camila Tobón Partner Shook, Hardy & Bacon LLP (Denver, CO) Lily Vakili Principal Faber Daeufer & Itrato PC (New York, NY) Celeste Warren Vice President, Global Diversity & Inclusion Center of Excellence Merck (Schwenksville, PA) Alana Wexler Senior Counsel Amgen (Thousand Oaks, CA)

Part of C5 Group’s LIFE SCIENCES GLOBAL SERIES

Pre-Conference Workshops JULY 26, 2022

Workshop A

Workshop B

Clock 9:00 am–12:30 pm

Clock 1:30 pm–5:00 pm

Think Tank on Devising Your 5-Year Plan for Continued Success: Strategic Advice from Senior Level Women Executives in the Life Sciences Legal Industry on Proactively Taking the Next Steps in Your Career

“Network Like a Leader” Master Class: Mastering Networking Skills and Behaviors to Drive Success

microphone-alt Marilyn A. Moberg, Partner, Reed Smith LLP Betania Glorio, Global Chief Compliance Officer, EMD Serono Diane Hilligoss, Associate Vice President and Assistant General Counsel, Eli Lilly and Company Lisa Jakob, Managing Counsel, Trademarks, Merck Don’t miss the chance to be part of this think tank on how to advance your life sciences career. Whether you are seeking an in-house, law firm or government position, an internal promotion or partnership, a board or C-Suite position, or to move from a seat at the boardroom table to the head of the table—this session will shed light on making and executing a plan to achieve your goal. Our esteemed workshop panelists will share their experiences on their personal roads to leadership, and will provide invaluable insights on: • Identifying your highest -priority career goals and plans for growth, as well as how to make strategic, proactive decisions to get to where you ultimately want to be

microphone-alt Diane Lifton, Senior Vice President, Legal, Sumitovant Biopharma, Inc.

Elena Rossano, Senior Counsel, Global Commercial Operations, Amgen Networking is important for everybody – particularly for women who are interested in becoming a leader in their organization or industry. A carefully crafted and well-maintained professional network could be one of the most powerful tools for career advancement in the life sciences. Understanding how to use your network to become more effective and achieve your career goals is key. This skills-driven master class will help you: • Understand how women need to approach professional networking differently than men • Maximize the value of networking functions and opportunities • Start worthwhile conversations by asking the right questions and embrace opportunities to make yourself memorable • Learn how to diversify your network: build relationships with individuals from a range of organizations and industries to gain a competitive edge • Leverage your professional networks and relationships to identify career opportunities

• Determining what experience you might lack and planning for how to get it

• Utilize your networks to maximize the benefits of your existing role and to anticipate strategic change within your organization

• Soliciting honest feedback on your strengths and weaknesses as a leader

• Use social media strategically to network effectively

• Stepping outside your comfort zone and pushing your boundaries to best enhance your skill set • Developing and sustaining sponsorship and mentor and mentee relationships with male and female advocates and supporters • Factoring external commitments and responsibilities into your decision on where you want to be in your 5-year trajectory

5:00

Welcome Cocktail Sponsored By:

Media Partners

4 | #WomeninLifeSciences

twitter: @ACI_Pharma linkedin: ACI’s Women Leaders in Life Sciences Law

Main Conference Day 1 JULY 27, 2022

7:15

Registration and Continental Breakfast

Breakfast Breakouts with the Advisory Board New to the conference this year? Or a returning attendee looking to make new connections? Take advantage of the opportunity to join one of our breakfast break-out tables where an esteemed Advisory Board member will facilitate attendee introductions and the sharing of information through a fun Q+A exercise. Kick off the conference by making connections that you can build upon during the remainder of the event and beyond. 8:15

Co-Chairs’ Opening Remarks and Audience Ice Breaker

• Navigating recent dramatic antitrust developments transforming the life sciences industry • How the nomination of Judge Ketanji Brown Jackson to the Supreme Court may impact future decisions affecting the life sciences industry • Understanding how anticipated new policies from the Biden Administration are likely to dramatically affect reimbursement, pricing, and innovation of prescription drugs • What implications will recent proposed amendments to Rule 702 (Daubert) have on the future of drug and device product liability litigation? 10:15 KEYNOTE INTERVIEW

Lessons in Leadership from the Covid-19 Pandemic

microphone-alt Tamara Joseph, Chief Legal Officer, Spero Therapeutics

Sally Susman Executive Vice President and Chief Corporate Affairs Officer Pfizer

Robin Walker, Chief Legal Officer, Goldfinch Bio In this opening session, our conference co-chairs will kick off the event with an interactive game of “2 truths 1 lie.” You will then break into small groups at your tables as our conference leaders take you through an icebreaking exercise using live polling.

YEAR IN REVIEW 8:45

Looking Back and Moving Forward: Analyzing Key Legal, Administrative, and Policy Developments Impacting the Life Sciences Industry and Influencing Your Career microphone-alt Aileen M. Fair, Senior Corporate Counsel, Litigation &

Government Investigations | Antitrust & Competition Law, Bristol Myers Squibb Deborah A. Logan, Associate General Counsel, EMD Serono, Inc.

Sapna Palla, Partner, Allen & Overy LLP Jeny Maier, Partner, Axinn, Veltrop & Harkrider LLP Honorable Teresa Rea, Partner, Crowell & Moring LLP (Former Acting Director of the United States Patent and Trademark Office) Moderator: Kellie Combs, Partner, Ropes & Gray LLP Join us for a high-level discussion of the most influential legal, regulatory, and political developments affecting all facets of the life sciences industry. Explore the impact that these developments will have on your future practices and careers in the year ahead and beyond. This panel will discuss topics including: • What we can glean from key agency developments? » How new leadership at the FDA, evolving approval standards, and the Administration’s New Intended Use Regulation are impacting the industry

11:00

Morning Networking Break

11:30

Making Your Personal Brand Work for You as a Woman in the Life Sciences Industry microphone-alt Amy Altshul, Senior Vice President, Head of Legal for Global R&D, Global Oncology and Global Commercial Activities, GlaxoSmithKline

Sheila Connor, Vice President and Chief US Counsel, Biogen Lauren Robinson, VP, Head of Legal Recruitment - Life Sciences, Larson Maddox Prajakta Sonalker, Counsel, Venable LLP Moderator: Brenda Herschbach Jarrell, Partner, Chair, Life Sciences Group, Choate Hall & Stewart LLP As a woman in today’s highly competitive life sciences market, building a strong personal brand is not always enough. Leveraging your brand’s unique value to stand out from the crowd is an essential step to making you a viable candidate for upward mobility within the industry. This panel will help you develop strategies for: • Harnessing your superpower: understanding what makes you unique and learning to articulate it • Positioning yourself in a way that differentiates you from your peers • Building your brand in a way that demonstrates your deep understanding of your client • Learning to become recognized as a thought leader in the life sciences arena and expanding your market presence • Identifying opportunities for growth within the life sciences legal market at large as well as in your organization 12:30

Networking Luncheon

» Anticipating how new leadership appointments at the PTO will impact life sciences innovation

AmericanConference.com/LSwomen • 888 224 2480

Part of C5 Group’s LIFE SCIENCES GLOBAL SERIES

ATTAINING SUCCESS IN THE HYBRID WORKPLACE 1:30

Town Hall on Work-Life “Integration” in the Life Sciences Industries: How We Can Strive to Achieve the Best of Both Worlds in a Hybrid Work Environment

3:15 3:30

Lessons Learned From the “Top 10” Court Decisions Impacting the Life Sciences Industry: Incorporating Key Takeaways Into Your Future Practice microphone-alt Regina Nelson, Counsel, Reed Smith LLP Chelsea A. Loughran, Shareholder, Wolf, Greenfield & Sacks, P.C.

microphone-alt Larissa Eustice, Senior Assistant General Counsel, Bayer Sheea Sybblis, Assistant General Counsel & Practice Group Leader, Genentech

Alison Hanstead, Partner, White & Case LLP Irena Royzman, Partner, Head of Life Sciences, Kramer Levin Naftalis & Frankel LLP

Joy Dowdle, Partner, Paul Hastings LLP Lisa Pirozzolo, Partner & Co-Chair of our IP Litigation Practice Group, Wilmer Cutler Pickering Hale and Dorr LLP As a result of the pandemic, many of us have learned to adopt the concept of “work-life integration,” which as opposed to work-life “balance,” largely abandons boundaries between work and life and instead embraces the notion that the two must coexist in harmony. This panel will tackle key questions such as:

Afternoon Networking Break

In this lightning round session, our panelists will walk you through the top 10 cases impacting the life sciences industry in the last year and their key implications for your future practice. Cases to be discussed will include: • GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., 7 F.4th 1320 (Fed. Cir. Aug. 5, 2021)

• What will work-life integration look like now that many of us will be shifting into a hybrid virtual/in-person work environment?

• Genus Medical Technologies LLC v. United States Food and Drug Administration, No. 20-5026 (D.C. Cir. 2021)

• How can we strive to achieve the best of both worlds, and avoid facing a “worst of both worlds” scenario?

• In re: Zofran (Ondansetron) Prods. Liability Litig., 2021 WL 2209871 (D. Mass. June 1, 2021)

• How have client expectations shifted due to the pandemic and what will expectations look like in a future hybrid work model?

• Biogen International GMBH v. Mylan Pharmaceuticals Inc., Appeal No. 2020-1933 (Fed. Cir. Nov. 30, 2021)

• How is virtual work creating a war for talent across the nation and will we ever be able to go back to the way things were pre-pandemic?

• Regents of Univ. of California v. Broad Institute, Inc., Patent Interference No. 106,115 (PTAB Feb. 28, 2022)

• How can women attain balance and best manage their time in a virtual or hybrid work model?

4:45

Let your voice be heard in this unique “open floor” session, designed to give attendees an opportunity to grab the microphone and add to the dialogue. 2:30

Focus Group on Ensuring the Success of the Next Generation of Female Life Sciences Lawyers: Tools for Effectively Managing, Training and Mentoring in a Virtual World

Analyzing How the Latest Tech and AI Innovations Are Transforming the Life Sciences Industry and Your Role in It microphone-alt Sonia Chen Arnold, Sr. Director, Assistant General Counsel – Consumer/Customer Operations, Eli Lilly and Company

Kate Middleton, Partner, Co-Lead of Digital Health Artificial Intelligence Team, Faegre Drinker Biddle & Reath LLP Camila Tobón, Partner, Shook, Hardy & Bacon LLP

microphone-alt Diane Lifton, Senior Vice President, Legal, Sumitovant Biopharma, Inc.

Dan Liu, Attorney, Loeb & Loeb LLP

Heather J. DiPietrantonio, PhD, Shareholder, Wolf, Greenfield & Sacks, P.C. Melanie Rupert, Partner, Paul Hastings LLP Colleen Tracy James, Partner, White & Case LLP With hybrid remote work looking like the way of the future, there is a growing concern that the physical distance will inevitably continue to reduce practical experiences for junior lawyers at the start of their careers. This panel will address topics including: • Overcoming a training deficit of junior attorneys as we emerge from the pandemic: How leadership can make up for limited opportunities by junior lawyers to observe senior lawyers interacting with clients/outside counsel or appearing in court • Taking deliberate measures to ensure that the junior generation will be adequately prepared for the passing of the torch by their predecessors

• Assessing the latest innovations and new developments in tech and AI affecting drugs, biologics, devices and diagnostics • Analyzing the host of complex legal challenges created by the latest innovations and the new and emerging regulatory landscapes aiming to govern these new technologies • Understanding the types of innovative licensing and collaboration agreements that are required to unlock the full potential of these new products • Exploring recent trends in IP disputes resulting from the novel form of many emerging products 5:30

Networking Cocktail Reception Sponsored By:

• Understanding how junior attorneys can play an active role in building their presence, reputation and skill set in a hybrid world

6 | #WomeninLifeSciences

twitter: @ACI_Pharma linkedin: ACI’s Women Leaders in Life Sciences Law

Main Conference Day 2 JULY 28, 2022

10:30

The Importance of Diversity in Clinical Trials: Implementing DE&I Principles Into the Development, Approval and Commercialization of Drugs and Devices microphone-alt Alana Wexler, Senior Counsel, Amgen

7:30

Continental Breakfast

8:30

Co-Chairs’ Recap of Day 1 and Morning Warm-Up Game 9:00 AUDIENCE POLLING

What Would You Do If….? Female Life Sciences Leaders Share Personal Stories of Combatting Exclusionary Practices in the Workplace, Boardroom, and Courtroom microphone-alt Gael Tisack, Global Head of Intellectual Property, Olympus Corporation

Sara Thompson, Shareholder, Chair, Pharmaceutical, Medical Device & Health Care Litigation Practice, Greenberg Traurig LLP Christiana Jacxsens Vice President, Deputy General Counsel, Head of Investigations and Litigation B. Braun Medical Inc. We’ve all been there. Perhaps you’ve had an idea appropriated by a male colleague, been left out of the “meeting after the meeting,” or watched a female colleague be excluded from a client interaction. This panel of senior level women executives will lead a polling exercise of “what would you do” – and share insights on: • How they’ve personally handled exclusionary practices in their own workplace • How women in the life sciences can work together to transform culture, policies and programs that will result in more equity and opportunity for women • How women in leadership roles can create opportunities for female employees to talk about their experiences of marginalization and discrimination and set the standards for behaviors in their own organizations

FOCUS ON DIVERSITY & INCLUSION 9:45 SPOTLIGHT SPEAKER

Diversity, Equity and Inclusion: How to Drive Sustaining Change Celeste Warren Vice President, Global Diversity & Inclusion Center of Excellence Merck 10:15

Morning Networking Coffee Break

Ronni Fuchs, Partner, Troutman Pepper LaShell Robinson, Director, Diversity & Inclusion in Clinical Trials, Takeda Pharmaceuticals The life sciences industry has seen a growing focus on patient diversity in clinical trials in recent years, with the Covid-19 pandemic shining an even brighter spotlight on the importance of achieving diverse patient recruitment. This panel will share critical insights on: • Analyzing the obstacles that continue to stifle patient diversity in clinical trials as well as the implications and consequences this has for patients • Identifying what industry can do in practice to improve diversity in clinical trials and overcome operational challenges to achieving diverse patient inclusion in clinical research • Understanding the different roles of sponsors, patients and investigators in conducting more equitable clinical trials • Examining the latest FDA guidance for drugmakers and medical device manufacturers regarding plans for making their studies more inclusive and setting goals for more diverse trial participant enrollment and retention 11:15

What Does ESG Mean for Life Sciences?: How Women in Leadership Can Effectively Integrate ESG Priorities Into Their Organization’s Strategy and Purpose microphone-alt Shannon Thyme Klinger, Chief Legal Officer, Moderna Lorie Foster, Division Counsel, Abbott Lisa Jakob, Managing Counsel, Trademark Group, Merck Anat Hakim, Senior Vice President, General Counsel and Secretary, Eli Lilly and Company As the world starts to adjust to life after the COVID-19 pandemic, we have seen that life sciences companies are focusing even greater attention on developing and strengthening their environmental, social, and corporate governance (ESG) initiatives. This panel will shed key insights on the role of female leadership in furthering ESG efforts, as well as: • Understanding how to embed ESG within your organization’s business to make it more financially and environmentally sustainable in the longer term • Operating under demonstrated ESG principles in a way that makes your company more attractive to investors, regulators, employees and customers • Strategies for assessing, improving and creating new and effective ESG practices and initiatives related to: » Environmental impact » Fostering diversity and inclusion initiatives » Access to healthcare and medicine pricing » Clinical trial practice, product quality and patient safety » Business ethics, integrity, and compliance » Human capital management » Supply chain management

AmericanConference.com/LSwomen • 888 224 2480

Part of C5 Group’s LIFE SCIENCES GLOBAL SERIES

12:15

Networking Luncheon

THE GLOBAL LIFE SCIENCES STAGE 1:15

Charting the Path for the Advancement of Women in the Global Life Sciences Sphere

If law firms and law departments are serious about developing women leaders, then they’ll send them to this conference. The who’s who of health care lawyers are here and there are multiple opportunities for informal networking and mentoring conversations. General Counsel, Enzyvant

microphone-alt Dorothy Flower, Partner, Head of Medical & Life Sciences, Reynolds Porter Chamberlain (RPC) (London, UK)

Carolina del Río, Partner, Dentons (Santiago, Chile) Yoshie Tanigawara, Associate Director, Corporate Strategy, Eisai Co., Ltd. This panel of international female life sciences leaders from the UK, Canada, Asia and South America will shed light on growth opportunities for women in the international life sciences legal sector, as well as key considerations for US attorneys looking to enter different international markets.

2:45 3:00

“ The Best Thing I Ever Learned from a Mentor — or a Mentee” microphone-alt Lisa LeCointe-Cephas, SVP, Chief Ethics and Compliance Officer, Merck

Katrina Long, Director, Corporate Counsel, Regeneron Pharmaceuticals, Inc.

2:00

Broadening Your Horizons: Key International Developments Impacting the Global Life Sciences Industry

Afternoon Break

Terra Reynolds, Partner, Latham & Watkins LLP Rebecca Clegg, Attorney, Axinn, Veltrop & Harkrider LLP

Eisai

Studies show that women with professional guides are five times more likely to advance in their workplaces. Join this panel of female leaders in life sciences law as they share:

Deirdre Parsons, Senior Director, Global Public Policy & Government Relations, Alnylam Pharmaceuticals

• Personal stories of the best lessons they’ve learned from their own mentors

microphone-alt Donna Meuth, Associate General Counsel, Intellectual Property,

Lily Vakili, Principal, Faber Daeufer & Itrato PC Research & Development • Considerations for cross-border clinical trials access and management • Addressing current and emerging CMC and supply chain challenges in the development and manufacturing of drug products

Intellectual Property

• Experiences with a mentee that have helped them in their own job performance and job satisfaction • Advice they would impart on the next generation of women preparing to lead in this space 3:45

End of Conference Wrap-Up: Champagne Toast and Takeaways

• Examining the latest strides being taken by Canada and the EU in connection to drug pricing and implications for cross-border transactions

As we wrap up the event, the conference co-chairs will share insights on key takeaways from the last two days. As we say cheers to a great event and celebrate one another with a glass of bubbly, attendees will write down one personal takeaway and how it could be used to improve her work or life. They will each then pass their paper to the woman to their right who will share the takeaway with the table, followed by an opportunity for group feedback and discussion.

• Survey of how different countries are currently treating the regulation of prescription drug advertising and how they contrast to the US

4:00

• Assessing the latest developments in international IP rights as well as anticompetitive concerns

Drug Commercialization and Pricing

South American and Asian Markets • Analyzing the evolving regulatory landscape in China: how recent changes to China’s pharma IP protection laws, vaccine laws and data privacy laws are impacting the way the life sciences industry is working there • Addressing the latest life sciences legal developments in South America, and major changes to the regulatory approval system for biosimilars, medicines and medical devices



Join Our Email List to Stay Connected SIGN UP TO RECEIVE EXCLUSIVE DISCOUNTS, OFFERS AND PROGRAM UPDATES AmericanConference.com/join-our-email-list/

8 | #WomeninLifeSciences

Conference Concludes

Venue Information American Conference Institute is pleased to offer our delegates a limited number of hotel rooms at a negotiated rate. To take advantage of these rates, please contact the hotel directly and quote “ACI’s Women in Life Sciences”. HOTEL: Omni Parker House ADDRESS: 60 School Street, Boston, MA 02108 RESERVATIONS: 617-227-8600 Please note that the guest room block cut-off date is June 26, 2022. After that date OR when the room block fills, guestroom availability and rate can no longer be guaranteed.

twitter: @ACI_Pharma linkedin: ACI’s Women Leaders in Life Sciences Law

Planning Ahead for Live Conferences: C5’s All Secure Safety Plan

As American Conference Institute and our partners plan for in-person events, we are committed to building and enhancing the planning and preparation with a view to offering our guests a safe place for live conference delivery. In addition, to ensure your safety, our event staff is fully vaccinated. All our events will adhere to official government and local authority guidance in addition to venue or location-specific regulations, and will follow the commitments below.

Attendance Screening All attendees will need to assert that at the time that they first attend the conference and for the 10 days prior: y Have not experienced any COVID-19 symptoms now or within the last 10 days. y Have not had close contact with any person with or suspected of having COVID-19 within the last 10 days.

Safety and Physical Distancing y Physical distancing protocols such as limiting attendance, directional signage and markers throughout the conference. y A conference room layout with planned seating for appropriate physical distancing. y We continue to work closely with our venue partners to ensure the safety of our attendees. Please check back frequently as we monitor and evolve our plan in the weeks ahead.

y Have not had a positive COVID-19 test within the last 10 days. y Have not been advised by any health authority, government agency or regulatory body, within the last 10 days, to self-isolate due to possible exposure to COVID-19. Link to COVID-19 symptoms: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/ symptoms.html We are closely monitoring industry best practices and will be evaluating further additional measures pertaining to vaccinations and on-site screening based on the advice of health authorities.

Reduced Touchpoints

Enhanced Communication y Advance communication to all attendees on what to expect and prepare for at the conference: from registration to conference materials to room layout to food and beverage options and more. y Education and training for the team to ensure we provide a safe and secure conference experience. y Distribution of local health-resource information in advance of the event. y Ongoing communication and advance planning with the venue regarding enhanced cleaning and sanitizing measures, response strategies and other onsite protocols.

Increased Cleaning and Sanitation

y Reduction of the physical distribution of onsite materials.

y Placement of hygiene stations throughout the conference including the registration area, meeting spaces and high frequency areas.

y Food and beverage options that ensure minimal handling and exposure.

y Availability of personal hygiene and safety products including facial coverings where available.

About us:

For over 35 years, C5 Group has proVided the opportunities that bring together business leaders, professionals and international experts from around the world to learn, meet, network and make the contacts that create the opportunities.

The C5 Group, comprising American Conference Institute, The Canadian Institute and C5 in Europe, is a leading global events and business intelligence company.

Our conferences and related products connect the power of people with the power of information, a powerful combination for business growth and success.

AmericanConference.com/LSwomen • 888 224 2480

Part of C5 Group’s LIFE SCIENCES GLOBAL SERIES

3 Ways to Register 

ONLINE:



AmericanConference.com/LSwomen

PRICING

EMAIL:



CustomerService@AmericanConference.com

All Access Pass (Main Conference + Both Workshops)

$1995

$2195

$2295

Conference Only

$1295

$1495

$1595

PHONE:

1-888-224-2480

REGISTRATION CODE:

B00-684-684L22.WEB CONFERENCE CODE:

684L22-BOS

Bringing a Team?* Workshops

$450 Each All program participants will receive an online link to access the conference materials as part of their registration fee. Additional copies of the Conference Materials available for $199 per copy. To update your contact information and preferences, please visit https://www.AmericanConference.com/preference-center/. Terms & conditions and refund/cancellation policies can be found at AmericanConference.com/company/faq/

WORRY FREE Registration

GUARANTEE

10% Conference Discount

5–6

15% Conference Discount

20% Conference Discount

Call 888-224-2480

Special Discount

Book with confidence! Register and pay to lock in your early rate and be eligible for a full refund until July 15. If you are unable to attend for any reason, you will have the following options: y A full credit note for you, or a colleague to attend another event. y A full refund. All cancellations and changes must be submitted to customerservice@americanconference.com by July 15.

hands-helping BECOME A SPONSOR

3–4

EARN CLE CREDITS

ACI offers financial scholarships for government employees, judges, law students, non-profit entities and others. For more information, please email or call customer service. * Team/group registrations are for in-person only and must be from the same organization/firm and register together in one transaction.

Continuing Legal Education Credits

With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, The Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.

Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as nontransitional for the purposes of CLE accreditation.

Don’t miss the opportunity to maximize participation or showcase your organization’s services and talent. For more information please contact us at: SponsorInfo@AmericanConference.com

ACI has a dedicated team which processes requests for state approval. Please note that event accreditation varies by state and ACI will make every effort to process your request.

ACI certifies this activity has been approved for CLE credit by the State Bar of California. ACI certifies this activity has been approved for CLE credit by the New York State Continuing Legal Education Board.

Questions about CLE credits for your state? Visit our online CLE Help Center at www.americanconference.com/accreditation/cle/